{
    "Case ID": "077890",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "legal_basis": [
                "s. 4(2)(b) of the PMNOC Regulations"
            ],
            "relevant_rule": [
                "Section 4(2)(b) of the PMNOC Regulations"
            ],
            "expert_testimony": [
                "expert testimony confirms they cover such formulations but lack specific claims required by law"
            ],
            "decision_reasoning": [
                "patents in question relate to controlled-release systems and tablets but do not explicitly claim paroxetine hydrochloride or its use"
            ],
            "conclusion_outcome": [
                "393 and 479 patents do not meet the requirements of s. 4(2)(b) and are ineligible for inclusion on the Patent Register"
            ],
            "cause_of_action": [
                "GSK sought judicial review after Health Canada rejected their patents for non-compliance with PMNOC Regulations"
            ],
            "procedure_followed": [
                "Court analyzed patent claims, expert evidence, and relevant case law to determine compliance with statutory requirements"
            ],
            "result_of_case": [
                "Application dismissed; patents remain ineligible for registration"
            ]
        }
    ]
}